02Dec
UK Life Sciences and Healthcare Newsletter - December 2020: The UK National Security and Investment Bill
The UK has announced a bill proposing a new system to screen transactions for national security risk, separate from the system of merger review operated by the Competition and Markets Authority. The National Security and Investment Bill has been in the pipeline since the publication of the National Security Risk Assessment in 2015, but has been delayed due to Brexit and the COVID-19 pandemic....
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-53811/
Related
Advance planning is crucial when you decide to sell your privately held business. You need to be at ...
Read More >
On July 3, 2020, the U.S. Department of Justice (“DOJ”) and the U.S. Securities and Exchange Commi...
Read More >
On June 26, 2019, Governor Ned Lamont signed a $43.4 billion budget for the 2020 and 2021 fiscal yea...
Read More >
On June 4, 2019, the Illinois legislature passed the Cannabis Regulation and Tax Act (the “Act”) (...
Read More >
Yesterday, the IRS increased almost every major retirement plan limit as part of its annual cost of ...
Read More >
As we begin 2020, the uncertainties facing businesses in the UK in the legal sense are, for most of ...
Read More >